Ko W C, Paterson D L, Sagnimeni A J, et al. Community-acquired ？Klebsiella pneumoniae？ bacteremia: global differences in clinical patterns[J]. Emerg Infect Dis, 2002, 8(2): 160-166. ？ [2]Han S H. Review of hepatic abscess from ？Klebsiella pneumoniae？. An association with diabetes mellitus and septic endophthalmitis [J]. West J Med, 1995, 162(3): 220-224. ？ [3]Lederman E R, Crum N F. Pyogenic liver abscess with a focus on ？Klebsiella pneumoniae？ as a primary pathogen: an emerging disease with unique clinical characteristics[J]. Am J Gastroenterol, 2005, 100(2): 322-331. ？ [4]Fung C P, Hu B S, Chang F Y, et al. A 5-year study of the seroepidemiology of ？Klebsiella pneumoniae？: high prevalence of capsular serotype K1 in Taiwan and implication for vaccine efficacy [J]. J Infect Dis, 2000, 181(6): 2075-2079. ？ [5]Lawlor M S, O’Connor C, Miller V L. Yersiniabactin is a virulence factor for ？Klebsiella pneumoniae？ during pulmonary infection [J]. Infect Immun, 2007, 75(3): 1463-1472. ？ [6]Ma L C, Fang C T, Lee C Z, et al. Genomic heterogeneity in ？Klebsiella pneumoniae？ strains is associated with primary pyogenic liver abscess and metastatic infection [J]. J Infect Dis, 2005, 192(1): 117-128. ？ [7]Gosset G, Zhang Z, Nayyar S, et al. Transcriptome analysis of Crp-dependent catabolite control of gene expression in ？Escherichia coli？[J]. J Bacteriol, 2004, 186(11): 3516-3524. ？ [8]Zhan L, Han Y, Yang L, et al. The cyclic AMP receptor protein, CRP, is required for both virulence and expression of the minimal CRP regulon in Yersinia pestis biovar microtus[J]. Infect Immun, 2008, 76(11): 5028-5037. ？ [9]Lin C T, Chen Y C, Jinn T R, et al. Role of the cAMP-dependent carbon catabolite repression in capsular polysaccharide biosynthesis in Klebsiella pneumoniae [J]. PLoS One, 2013, 8(2): e54430. [10]Meyer M, Dimroth P, Bott M. Catabolite repression of the citrate fermentation genes in ？Klebsiella pneumoniae: evidence for involvement of the cyclic AMP receptor protein[J]. J Bacteriol, 2001, 183(18): 5248-5256. ？ [11]Kalivoda E J, Stella N A, O’Dee D M, et al. The cyclic AMP-dependent catabolite repression system of Serratia marcescens mediates biofilm formation through regulation of type 1 fimbriae [J]. Appl Environ Microbio, 2008 , 74 (11): 3461-3470. ？ [12]Muller C M, Aberg A, Straseviciene J, et al. Type 1 fimbriae, a colonization factor of uropathogenic ？Escherichia coli, are controlled by the metabolic sensor CRP-cAMP[J]. PLoS Pathog, 2009, 5(2): e1000303. ？ [13]高钰双, 冯甜, 邱景富, 等. 肺炎克雷伯菌基因无痕敲除方法的建立[J]. 军事医学, 2013, 37(6): 431-433. ？ [14]Duncan M J, Mann E L, Cohen M S, et al. The distinct binding Specificities exhibited by enteorbacterial type1 fimbriae are determined by their fimbrial shafts [J]. J Biol Chem, 2005, 280(45): 37707-37716. ？ [15]Podschun R, Ullmann U. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors[J]. Clin Microbiol Rev, 1998, 11(4): 589-603. ？ [16]Scharger H M, Rheinwald J G, Wessels M R. Hyaluronic acid capsule and the role of streptococcal entry into keratinocytes invasive skin infection [J]. J Clin Invest, 1996, 98(9): 1954-1958. ？ [17]Sahly H, Podschun R, Oelschlaeger T A, et al. Capsule impedes adhesion to and invasion of epithelial cells by ？Klebsiella Pneumoniae[J]. Inefet Immun, 2000, 68(12): 6744-6749.
